123 related articles for article (PubMed ID: 36571247)
1. Prevalence of Adenopathy at Chest Computed Tomography After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2.
McGuinness G; Alpert JB; Brusca-Augello G; Azour L; Ko JP; Tamizuddin F; Gozansky EK; Moore WH
J Comput Assist Tomogr; 2023 Jan-Feb 01; 47(1):50-57. PubMed ID: 36571247
[TBL] [Abstract][Full Text] [Related]
2. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
3. Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era.
Giordano A; Gallicchio R; Milella M; Storto R; Nardelli A; Pellegrino T; Nappi A; Di Cosola M; Storto G
Curr Pharm Des; 2024; 30(10):798-806. PubMed ID: 38454762
[TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
van Nijnatten TJA; Jochelson MS; Lobbes MBI
Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513
[TBL] [Abstract][Full Text] [Related]
5. [
Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
[TBL] [Abstract][Full Text] [Related]
6. Axillary adenopathy detected on breast MRI following COVID-19 vaccination: outcomes and follow-up recommendations.
Nguyen DL; Chen X; Kwak L; Oluyemi ET; Mullen LA; Ambinder EB
Clin Imaging; 2023 Jan; 93():1-3. PubMed ID: 36335676
[TBL] [Abstract][Full Text] [Related]
7. Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination.
Horvat JV; Sevilimedu V; Becker AS; Perez-Johnston R; Yeh R; Feigin KN
Eur Radiol; 2022 Aug; 32(8):5752-5758. PubMed ID: 35247087
[TBL] [Abstract][Full Text] [Related]
8. Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.
Yoshikawa T; Miki S; Nakao T; Koshino S; Hayashi N; Abe O
Radiology; 2023 Jan; 306(1):270-278. PubMed ID: 36098641
[TBL] [Abstract][Full Text] [Related]
9. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
[TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
11. Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation.
Igual-Rouilleault AC; Soriano I; Quan PL; Fernández-Montero A; Elizalde A; Pina L
Eur Radiol; 2022 May; 32(5):3199-3206. PubMed ID: 34655312
[TBL] [Abstract][Full Text] [Related]
12. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination.
Edmonds CE; Zuckerman SP; Conant EF
AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649
[TBL] [Abstract][Full Text] [Related]
13. Imaging of COVID-19 Vaccine-Related Axillary Lymphadenopathy: Initial Outcomes Based on US Features of Axillary Lymph Nodes.
Ahn RW; Porembka JH; Mootz AR; Goudreau SH; Dogan BE; Xi Y; Seiler SJ
J Breast Imaging; 2023 Mar; 5(2):135-147. PubMed ID: 38416930
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccine associated axillary lymphadenopathy - A systematic review.
Co M; Wong PCP; Kwong A
Cancer Treat Res Commun; 2022; 31():100546. PubMed ID: 35334408
[TBL] [Abstract][Full Text] [Related]
15. Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features.
Cocco G; Delli Pizzi A; Taraschi AL; Boccatonda A; Corvino A; Ucciferri C; Falasca K; Caulo M; Vecchiet J
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208521
[No Abstract] [Full Text] [Related]
16. Axillary lymph node imaging in mRNA, vector-based, and mix-and-match COVID-19 vaccine recipients: ultrasound features.
Igual-Rouilleault AC; Soriano I; Elizalde A; Quan PL; Fernandez-Montero A; Sobrido C; Pina L
Eur Radiol; 2022 Oct; 32(10):6598-6607. PubMed ID: 35554651
[TBL] [Abstract][Full Text] [Related]
17. Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach.
Lehman CD; Lamb LR; D'Alessandro HA
AJR Am J Roentgenol; 2021 Sep; 217(3):584-586. PubMed ID: 33617288
[TBL] [Abstract][Full Text] [Related]
18. Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
Özütemiz C; Krystosek LA; Church AL; Chauhan A; Ellermann JM; Domingo-Musibay E; Steinberger D
Radiology; 2021 Jul; 300(1):E296-E300. PubMed ID: 33625300
[TBL] [Abstract][Full Text] [Related]
19. Intensity of hypermetabolic axillary lymph nodes in oncologic patients in relation to timeline following COVID-19 vaccination.
Su N; Wiefels C; Klein R; Zeng W; Abbaspour F
J Med Imaging Radiat Sci; 2022 Jun; 53(2):219-225. PubMed ID: 35131216
[TBL] [Abstract][Full Text] [Related]
20. Unilateral Axillary Lymphadenopathy after the Inactivated SARS-COV-2 (CoronaVac) Vaccine: Ultrasonographic Imaging.
Elverici E; Özsoy A; Sayın B; Gökhan MB; Özkan E
Balkan Med J; 2023 Jan; 40(1):28-33. PubMed ID: 36421031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
